These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30188676)

  • 1. [ADRENERGIC AND IMIDAZOLINE MECHANISMS OF CIRCULATION CENTRAL REGULATION IN RATS OF DIFFERENT LINES].
    Tsyrlin VA; Kuzmenko NV; Pliss MG
    Ross Fiziol Zh Im I M Sechenova; 2016 Apr; 102(4):442-53. PubMed ID: 30188676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat.
    Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y
    Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose of moxonidine within the rostral ventrolateral medulla improves the baroreflex sensitivity control of sympathetic activity in hypertensive rat.
    Wang JL; Wang L; Wu ZT; Yuan WJ; Su DF; Ni X; Yan JJ; Wang WZ
    Acta Pharmacol Sin; 2009 Dec; 30(12):1594-600. PubMed ID: 19960005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
    Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
    Cao C; Kang CW; Kim SZ; Kim SH
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the I(1) imidazoline/alpha(2)-adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats.
    Shannon HE; Lutz EA
    Pain; 2000 Mar; 85(1-2):161-7. PubMed ID: 10692615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic dose-dependent modulation of cardiac parasympathetic activity by moxonidine, an imidazoline I1-receptor agonist.
    Turcani M
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):524-35. PubMed ID: 19034032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular responses to emotional stress during activation of the brain imidazoline receptors].
    Kuz'menko NV; Pliss MG; Tsyrlin VA
    Ross Fiziol Zh Im I M Sechenova; 2002 Mar; 88(3):356-62. PubMed ID: 12013730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
    Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
    Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazoline I(1) receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease.
    Tanabe M; Hashimoto M; Ono H
    Eur J Pharmacol; 2008 Jul; 589(1-3):102-5. PubMed ID: 18602099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of spinal alpha(2)-adrenoceptor and I(1)-imidazoline receptor activation on hindlimb movement induction in spinal cord-injured mice.
    Lapointe NP; Ung RV; Rouleau P; Guertin PA
    J Pharmacol Exp Ther; 2008 Jun; 325(3):994-1006. PubMed ID: 18364473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of I(1)-imidazoline receptors and alpha2-adrenoceptors in hemodynamic effects of moxonidine administration into the rostroventrolateral medulla.
    Khokhlova ON; Murashev AN; Medvedev OS
    Bull Exp Biol Med; 2001 Apr; 131(4):336-9. PubMed ID: 11550020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.
    Velliquette RA; Kossover R; Previs SF; Ernsberger P
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):300-12. PubMed ID: 16416266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
    Tolentino-Silva FP; Haxhiu MA; Waldbaum S; Dreshaj IA; Ernsberger P
    Brain Res; 2000 Apr; 862(1-2):26-35. PubMed ID: 10799665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.